Results 141 to 150 of about 15,823 (164)

Docetaxel versus androgen receptor pathway inhibitors as first-line therapy for metastatic castration-resistant prostate cancer after doublet therapy: a multicenter retrospective study from Saudi Arabia. [PDF]

BMC Urol
Bazarbashi S, Abdelmotal AS, Arabi T, Fallatah W, Alzannan N, Elhassan T, Aseafan M, Mahroos M, Aljishi M, Busbaih A, Aldandan R, Rauf MS, Almugbel FA, Azam F, Almansour M.   +14 more
europepmc   +1 more source

AR and Beyond: ctDNA Maps Resistance Evolution in mCRPC. [PDF]

Clin Cancer Res
Chauhan PS, Pachynski RK, Maher CA, Chaudhuri AA.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Therapy-Related Myeloid Neoplasms After [¹⁷⁷Lu]Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Series

Journal of Nuclear Medicine
[177Lu]Lu-prostate-specific membrane antigen (PSMA) therapy has a favorable toxicity profile in patients with metastatic castration-resistant prostate cancer (mCRPC). Therapy-related myeloid neoplasm (t-MN) has been described after [177Lu]Lu-DOTATATE but has not, to our knowledge, yet been reported after [177Lu]Lu-PSMA.
Michal, Eifer, Duncan E K, Sutherland, Isaac, Goncalves, James P, Buteau, Lewis, Au, Arun A, Azad, Louise, Emmett, Grace, Kong, Louise, Kostos, Aravind S, Ravi Kumar, Edmond M, Kwan, Elizabeth, Medhurst, Shahneen, Sandhu, Ben, Tran, Alexander W, Wyatt, Michael S, Hofman   +15 more
openaire   +2 more sources

Advanced Therapeutic Options for Treatment of Metastatic Castration Resistant Prostatic Adenocarcinoma

Frontiers in Pharmacology, 2021
Sadia Anjum, Faiza Naseer, Tahir Ahmad   +2 more
exaly  

Indirect Comparison of Darolutamide versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer

Journal of Urology, 2021
, Rajeev Ayyagari, Susan Halabi
exaly  

Distinct Response to Platinum-Based Chemotherapy among Patients with Metastatic Castration-Resistant Prostate Cancer Harboring Alterations in Genes Involved in Homologous Recombination

Journal of Urology, 2021
Fan Liancheng, Baijun Dong, Yanqing Wang   +2 more
exaly  

Studies on Prostatic Cancer: I. The Effect of Castration, Of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate

Ca-A Cancer Journal for Clinicians, 1972
C Huggins
exaly  

Clinical development of novel therapeutics for castration‐resistant prostate cancer

Ca-A Cancer Journal for Clinicians, 2012
William Oh, Matthew Galsky, Alexander Small   +2 more
exaly  

Neuroendocrine differentiation of prostatic adenocarcinoma – an important cause for castration-resistant disease recurrence

Journal of Laboratory Medicine, 2019
João Lobo
exaly